Abstract
In rat islets, progesterone caused a prompt concentration-dependent inhibition of glucose-stimulated insulin release with an IC50 of 10 μM at 8.4 mM glucose. The inhibition was specific since both testosterone and 17β-estradiol had no such effect. The degree of inhibition was similar in islets from male and female rats. The inhibition was not blocked in PTX-treated islets thus ruling out the Gi/Go proteins as mediators of the inhibition. Progesterone inhibited both glucose- and BayK-8644-stimulated insulin secretion in HIT-T15 cells and the IC50 vs. 10 mM glucose was also 10 μM. There was no effect on intracellular cyclic AMP concentration in the presence 0.2 and 10 mM glucose. Progesterone decreased [Ca2+]i under all conditions tested. The decrease in [Ca2+]i was due to blockade of the L-type voltage-dependent Ca2+ channels. Under Ca2+-free conditions, progesterone did not inhibit the stimulation of insulin release due to the combination of glucose, phorbol ester and forskolin. Thus blockade of Ca2+ entry appears to be the sole mechanism by which progesterone inhibits insulin release. As progesterone covalently linked to albumin had a similar inhibitory effect as progesterone itself, it is concluded that the steroid acts at the outer surface of the β-cell plasma membrane. These effects would be classified as either AI or AIIb in the Mannheim classification of nongenomically initiated steroid actions.
Similar content being viewed by others
REFERENCES
Wehling, M. (1997) Annu. Reû. Physiol. 59: 365–393.
Beato, M. (1989) Cell 56: 335–344.
Evans, R. M. (1988) Science 240: 889–895.
Fuller, P. J. (1991) FASEB J. 5: 3092–3099.
McEwen, B. S. (1991) Trends Pharmacol. Sci. 12: 141–147.
Lan, N. C., Chen, J. S., Belelli, D., Pritchett, D. B., Seeburg, P. H., and Gee, K. W. (1990) Eur. J. Pharmacol. 188: 403–406.
Su, T. P., London, E. D., and Jaffe, J. H. (1988) Science 240: 219–221.
Ke, F. C. and Ramirez, V. D. (1987) Neuroendocrinology 45: 514–517.
Blackmore, P. F. (1993) Cell Signal. 5: 531–538.
Cheng, F. P., Gadella, B. M., Voorhout, W. F., Fazeli, A., Bevers, M. M., and Colenbrander, B. (1998) Biol. Reprod. 59: 733–742.
Wasserman, W. J., Pinto, L. H., O'Conner, C. M. and Smith, L. D. (1980) Proc. Natl. Acad. Sci. USA 77: 1534–1536.
Sadler, S. E. and Maller, J. L. (1985) Adû. Cyclic Nucleotide Protein Phosphorylation Res. 19: 179–194.
Ryan, E. A. and Enns, L. (1988) J. Clin. Endocrinol. Metab. 67: 341–347.
Sutter-Dub, M. T., Dazey, B., Vergnaud, M. T., and Madec, A. M. (1981) Diabete Metab. 7: 97–104.
Kalkhoff, R. K. (1982) Am. J. Obstet. Gynecol. 142: 735–738.
Costrini, N. V. and Kalkhoff, R. K. (1971) J. Clin. Inûest. 50: 992–999.
Hager, D., Georg, R. H., Leiter, J. W., and Beck, P. (1972) Endocrinology 91: 977–981.
Howell, S. L., Tyhurst, M. and Green, I. C. (1977) Diabetologia 13: 579–583.
Green, I. C., Howell, S. L., el Seifi, S., and Perrin, D. (1978) Diabetologia 15: 349–355.
Lacy, P. E. and Kostianovsky, M. (1967) Diabetes 16: 35–39.
Scharp, D. W., Kemp, C. B., Knight, M. J., Ballinger, W. F., and Lacy, P. E. (1973) Transplantation 16: 686–689.
Meglasson, M. D., Nelson, J., Nelson, D., and Erecinska, M. (1989) Metabolism 38: 1188–1195.
de Souza, C. J., Rutledge, P. A., Meier, A. H., and Atwater, I. (1993) Pancreas 8: 726–731.
Bradford, M. M. (1976) Anal. Biochem. 72: 248–254.
Sharp, G. W. G. (1996) Am. J. Physiol. 271: C1781-C1799.
Komatsu, M., McDermott, A. M., Gillison, S. L., and Sharp, G. W. G. (1995) Endocrinology 136: 1857–1863.
Komatsu, M., Schermerhorn, T., Aizawa, T., and Sharp, G. W. G. (1995) Proc. Natl. Acad. Sci. USA 92: 10728–10732.
Sanchez-Bueno, A., Sancho, M. J., and Cobbold, P. H. (1991) Biochem. J. 280: 273–276.
Blackmore, P. F., Beebe, S. J., Danforth, D. R., and Alexander, N. (1990) J. Biol. Chem. 265: 1376–1380.
Bielefeldt, K., Waite, L., Abboud, F. M., and Conklin, J. L. (1996) Amer. J. Physiol. 271: G370-G376.
Dar, D. E. and Zinder, O. (1997) Neuropharmacology 36: 1783–1788.
Shivaji, S. and Jagannadham, M. V. (1992) Biochim. Biophys. Acta. 1108: 99–109.
Falkenstein, E., Norman, A. W., and Wehling, M. (2000) J. Clin. Endocrinol. Metab. 85: 2072–2075.
Alexander, N. J., Kim, H. K., Blye, R. R., and Blackmore, P. F. (1996) Steroids 61: 116–125.
Morrill, G. A., Ma, G. Y. and Kostellow, A. (1997) Biochem. Biophys. Res. Comm. 232: 213–217.
Ramirez, V. D., Zheng, J. and Siddique, K. M. (1996) Cell Mol. Neurobiol. 16: 175–198.
Luconi, M. et al. (1998) J. Clin. Endocrinol. Metab. 83: 877–885.
Falkenstein, E., Meyer, C., Eisen, C., Scriba, P. C., and Wehling, M. (1996) Biochem. Biophys. Res. Comm. 229: 86–89.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Straub, S.G., Sharp, G.W.G., Meglasson, M.D. et al. Progesterone Inhibits Insulin Secretion by a Membrane Delimited, Non-genomic Action. Biosci Rep 21, 653–666 (2001). https://doi.org/10.1023/A:1014773010350
Issue Date:
DOI: https://doi.org/10.1023/A:1014773010350